The Expression of p53, CD44, Ki-67, and HER-2/neu Markers in Gastric Cancer and Its Association with Histopathological Indicators: A Retrospective Study

Volume 21, Issue 6, June 2020, Pages 1607-1614

Mahsa Ahadi; Afshin Moradi; Leila Musavinejad; Abolfazl Movafagh; Arsham Moradi

• View Article
• PDF 900.86 K

Chromogenic In Situ Hybridisation Test for Breast Cancer Patients with Equivocal IHC Results - a Study from Iran

Volume 16, Issue 17, December 2015, Pages 7695-7700

• View Article
• PDF 513.63 K

Overexpression of HER-2/neu in Patients with Prostatic Adenocarcinoma

Volume 15, Issue 15, December 2014, Pages 6425-6428

• View Article
• PDF 408.31 K

Anti-HER-2×anti-CD3 Bi-specific Antibodies Inhibit Growth of HCT-116 Colorectal Carcinoma Cells in Vitro and in Vivo

Volume 13, Issue 6, June 2012, Pages 2795-2798

• View Article
• PDF 454.85 K

Immunohistochemical (IHC) HER-2/neu and Fluorescent-In–Situ Hybridization (FISH) Gene Amplification of Breast Cancer in Indian Women

Volume 12, Issue 1, January 2011, Pages 179-183

• View Article
• PDF 343.04 K

Determination of HER-2/neu by Chromogenic in Situ Hybridization on Borderline (2+) Immunohistochemistry Cases in Carcinoma Breast

Volume 12, Issue 1, January 2011, Pages 211-214

• View Article
• PDF 341.8 K

Lack of Prognostic Significance of HER-2/neu in Early Epithelial Ovarian Cancer

Volume 8, Issue 4, April 2007, Pages 502-506

• View Article
• PDF 77.99 K